NCT07566364 2026-05-20Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRDM.D. Anderson Cancer CenterPhase 2 Not yet recruiting30 enrolled
NCT06075238 2023-10-10Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCTSichuan UniversityPhase 2 Not yet recruiting68 enrolled